Latest News and Press Releases
Want to stay updated on the latest news?
- 
                            
Dublin, Nov. 03, 2025 (GLOBE NEWSWIRE) -- The "Chronic Obstructive Pulmonary Disease (COPD) Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033" has been added to ...
 - 
                            
Dublin, Oct. 23, 2025 (GLOBE NEWSWIRE) -- The "United States Chronic Obstructive Pulmonary Disease (COPD) Market Report by Type, Treatment, Distribution Channels, States and Company Analysis,...
 - 
                            
Dublin, Oct. 02, 2025 (GLOBE NEWSWIRE) -- The "Europe At-home Respiratory Care Services Market Size, Share & Trends Analysis Report by Therapy (Oxygen Therapy, Non-Invasive Ventilation), by...
 - 
                            
Monaghan Medical announces the nationwide availability of the AeroChamber2go® Valved Holding Chamber (VHC), a portable inhaler chamber and case.
 - 
                            
The new AeroChamber2Go™ chamber combines proven inhaler therapy support with a discreet, portable design, now at Walmart Pharmacies nationwide
 - 
                            
Austin, TX, USA, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “High Flow Nasal Cannula Market Size, Trends and Insights By Product Type (Single...
 - 
                            
The Lung Health Foundation is calling on the Ontario government to include vital respiratory services in their $1.8 billion Primary Care investment.
 - 
                            
Pneumagen’s intranasal broad-spectrum antiviral therapy reduced infection, improved symptoms and severity and reduced viral load in a Phase II influenza study in data published in the high-impact,...
 - 
                            
Translational Data Presented at EACCI Illustrate a Mechanism of Greater Potency with Verekitug, a Novel Antibody Antagonist of the TSLP Receptor
 - 
                            
Upstream Bio to Present Mechanistic Insights into Verekitug’s Enhanced Potency via TSLP Receptor Targeting at EACCI 2025